Using Fragment-Based Technologies to Target Protein-Protein Interactions

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|30|4685-4696

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.30, 2012-10, pp. : 4685-4696

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Target validation and drug discovery using genomic and protein–protein interaction technologies

By Pillutla Renuka C   Fisher Paul B   Blume Arthur J   Goldstein Neil I  

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 4, 2002-08 ,pp. : 517-531

Informa Healthcare

Access to resources Recommend Favorite

Fragment-Based Discovery of Inhibitors of Protein Kinase B

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 18, 2009-12 ,pp. : 1705-1717

Bentham Science Publishers

Access to resources Recommend Favorite

Fragment-based lead discovery on G-protein-coupled receptors

By Visegrády András  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 7, 2013-08 ,pp. : 811-820

Informa Healthcare

Access to resources Recommend Favorite

G Protein-Coupled Receptors - Targets for Fragment-based Drug Discovery

By  

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 24, 2015-01 ,pp. : 2523-2527

Bentham Science Publishers

Access to resources Recommend Favorite

Druggable Orthosteric and Allosteric Hot Spots to Target Protein-protein Interactions

By  

Current Pharmaceutical Design, Vol. 20, Iss. 8, 2014-03 ,pp. : 1293-1301

Bentham Science Publishers

Access to resources Recommend Favorite